Adcentrx begins patient dosing in phase 1a/b study of ADRX-0405, a potential first-in-class ADC targeting STEAP1 to treat advanced solid tumours: San Diego, California Wednesday, ...
Norgine submits MAA to EMA for eflornithine in high-risk neuroblastoma: Netherlands Wednesday, January 8, 2025, 17:00 Hrs [IST] Norgine, a uniquely positioned, specialty pharmaceu ...
No need to get anxious over HMPV virus infection, it is not dangerous like coronavirus: Experts: Our Bureau, Chennai Wednesday, January 8, 2025, 16:45 Hrs [IST] Although two cases ...
Medanta strengthens its Renal Care Institute, appoints leading urologist Dr Sanjay Gogoi as chairman: Our Bureau, Mumbai Wednesday, January 8, 2025, 16:15 Hrs [IST] Reinforcing it ...
WuXi Biologics grants exclusive global rights of trispecific t-cell engager to Candid Therapeutics: Shanghai Wednesday, January 8, 2025, 15:00 Hrs [IST] WuXi Biologics, a leading ...
AIOCD seeks Ministry of Railways to withdraw plans to rope in online pharmacies for home delivery of medicines: Our Bureau, New Delhi Wednesday, January 8, 2025, 14:10 Hrs [IST] T ...
US FDA issues new draft guidance aimed to help improve performance of pulse oximeters across skin tones: Maryland Wednesday, January 8, 2025, 14:00 Hrs [IST] The US Food and Drug ...
Arcturus Therapeutics initiates patient dosing in phase 2 multiple ascending dose studies for CF and OTC deficiency: San Diego Wednesday, January 8, 2025, 13:00 Hrs [IST] Arcturus ...
Bayer seeks China NMPA marketing authorization for ARi darolutamide in combo with ADT in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, January 8, 2 ...
Botanic Healthcare raises Rs. 250 crore to drive global expansion and market leadership: Our Bureau, Bengaluru Wednesday, January 8, 2025, 11:50 Hrs [IST] Botanic Healthcare, Indi ...
US FDA issues comprehensive draft guidance for developers of AI -enabled medical devices: Maryland Wednesday, January 8, 2025, 11:00 Hrs [IST] The US Food and Drug Administration ...